BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 21325937)

  • 1. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):81-7. PubMed ID: 22789492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of adjuvant chemoradiotherapy for ampulla of Vater cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):436-41. PubMed ID: 19394162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant chemoradiotherapy for duodenal cancer: a single center experience.
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2012 Dec; 35(6):533-6. PubMed ID: 21659832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is duodenal invasion a relevant prognosticator in patients undergoing adjuvant chemoradiotherapy for distal common bile duct cancer?
    Kim K; Chie EK; Jang JY; Kim SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1186-90. PubMed ID: 19962835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy for extrahepatic bile duct cancer with gross residual disease after surgery.
    Park HJ; Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Anticancer Res; 2014 Nov; 34(11):6685-90. PubMed ID: 25368275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD24 expression predicts distant metastasis in extrahepatic bile duct cancer.
    Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
    World J Gastroenterol; 2013 Mar; 19(9):1438-43. PubMed ID: 23539485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrahepatic bile duct cancers: surgery alone versus surgery plus postoperative radiation therapy.
    Gwak HK; Kim WC; Kim HJ; Park JH
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):194-8. PubMed ID: 19910130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.
    Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Am J Clin Oncol; 2016 Aug; 39(4):346-9. PubMed ID: 24755662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant radiation therapy for microscopic residual tumor after resection of extrahepatic bile duct cancer.
    Matsuda T; Fujita H; Harada N; Kunimoto Y; Tanaka T; Kimura T; Kitaoka H; Asano E; Hosono M; Hayashi T; Ogino K
    Am J Clin Oncol; 2013 Oct; 36(5):461-5. PubMed ID: 22706178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of adjuvant chemoradiotherapy for resected extrahepatic biliary tract cancer.
    Kim TH; Han SS; Park SJ; Lee WJ; Woo SM; Moon SH; Yoo T; Kim SS; Kim SH; Hong EK; Kim DY; Park JW
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e853-9. PubMed ID: 21497455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma.
    Lin JC; Jan JS; Chen KY; Hsu CY; Liang WM; Wang WY
    Head Neck; 2003 Jun; 25(6):438-50. PubMed ID: 12784235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer.
    Quero L; Bouchbika Z; Kouto H; Baruch-Hennequin V; Gornet JM; Munoz N; Cojean-Zelek I; Houdart R; Panis Y; Valleur P; Aparicio T; Maylin C; Hennequin C
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):574-80. PubMed ID: 22099038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer.
    Kim BH; Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
    Am J Clin Oncol; 2017 Apr; 40(2):158-162. PubMed ID: 25171299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is c-Met oncoprotein expression an adverse prognosticator in extrahepatic bile duct cancer treated with curative resection followed by adjuvant chemoradiotherapy?
    Park HJ; Kim K; Paik JH; Chie EK; Kim S; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
    Clin Transl Oncol; 2016 Jun; 18(6):625-31. PubMed ID: 26459257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.